Clinical Trial Update: Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety results for desloratadine (MK-4117) in Japanese participants with eczema/dermatitis and dermal pruritus have been completed and post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis
• Pruritus

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Eczema, Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2014-11-19